Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

TWi Biotechnology Receives FDA Protocols for Gout Drug

December 12, 2014 10:30 am | News | Comments

TWi Biotechnology Inc. has received US FDA and Taiwan FDA approval of a protocol for a Phase 2 clinical trial of gout drug. Read more...                     

TOPICS:

Merck Helps Africa Fight Parasitic Worm Disease

December 12, 2014 10:22 am | News | Comments

Merck announced that Ethiopia will receive around 13 million praziquantel tablets in 2015. Read more...                          

TOPICS:

Abbott Acquires Veropharm for $305M

December 12, 2014 9:56 am | News | Comments

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Read more...                        

TOPICS:
Advertisement

Team Discovers Reasons for Malaria's Drug Resistance

December 12, 2014 9:38 am | by Nanyang Technological University | News | Comments

Scientists have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease. Read more...                

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Mali: Last Known Ebola Case Cured, Released

December 12, 2014 9:22 am | by Sarah Dilorenzo - Associated Press | News | Comments

The last Ebola patient being treated in Mali has survived the disease and been released. Read more...                           

TOPICS:

Minnesota Board Won't Set Rules on Execution Drugs

December 11, 2014 2:09 pm | by Brian Bakst - Associated Press | News | Comments

Minnesota pharmacy regulators declined Wednesday to set a pioneering policy sought by death-penalty opponents that would explicitly bar the manufacture of lethal drugs for use in executions elsewhere. Read more...        

TOPICS:
Advertisement

Drug Class Shows Promising Results for Breast Cancer Therapy

December 11, 2014 11:53 am | News | Comments

A new class of drugs could help overcome resistance to standard treatments. Read more...                             

TOPICS:

Epidemics Are Optional

December 11, 2014 11:37 am | by Kalpana Jain, Harvard Divinity School Communications | News | Comments

The large number of deaths from the Ebola virus is primarily due to the lack of sufficient medical care where it’s needed most. Read more...                    

TOPICS:

Merck Advancing Breast Cancer Drug to Mid-Stage

December 11, 2014 11:33 am | by Linda A. Johnson - AP Business Writer | News | Comments

Merck said it will start mid-stage patient tests of Keytruda in the first half of 2015. Read more...                           

TOPICS:

Patient with Exposure to Ebola to be Admitted at NIH Clinical Center

December 11, 2014 11:30 am | News | Comments

Later today, the National Institutes of Health expects to admit a patient with exposure to the Ebola virus to the NIH Clinical Center’s special clinical studies unit for observation and to enroll in a clinical protocol. The patient is an American nurse who was volunteering services in an Ebola treatment unit in Sierra Leone. Read more...

TOPICS:

Supporting Drug Development Process with Raman Spectroscopy

December 11, 2014 11:25 am | by Kathleen A. Martin, Ph.D., Senior Research Chemist, McCrone Associates, Inc. | Articles | Comments

Raman spectroscopy has steadily gained a wider role in the pharmaceutical industry because of its applicability to several important aspects of drug development and manufacturing. Read more...                         

TOPICS:

Ebola Vaccine Trial Suspended After Side Effects

December 11, 2014 9:17 am | by Associated Press | News | Comments

Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. Read more...                                

TOPICS:

‘Placebo Therapy’ Ineffective For Long-Term Chronic Pain Relief

December 11, 2014 9:13 am | News | Comments

Scientists at the University of Liverpool have shown that ‘placebo therapy’ could be effective for short-term pain relief in patients with Complex Regional Pain Syndrome (CRPS), but does not have a lasting impact. Read more...                              

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading